Galapagos reported 176.37M in Operating Expenses for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
AstraZeneca AZN:LN 5.41B 416M
Biogen BIIB:US $ 2289.7M 582.6M
Genmab GEN:DC 866M 88M
Gilead Sciences GILD:US $ 8126M 4980M
GlaxoSmithKline GSK:LN 477.4M 230.2M
Merck MRK:GR 362.8M 2.6M
Neurocrine Biosciences NBIX:US $ 225.8M 47.6M
Novartis NOVN:VX 9.27B 694M
Vertex Pharmaceuticals VRTX:US $ 806.45M 11.57M
YTE INCY:US $ 45.73M 77.52M